DPHARMA
Quarterly rpt on consolidated results for the financial period ended 30/6/2005
DUOPHARMA BIOTECH BHD |
Quarterly report for the financial period ended | 30/06/2005 |
Quarter | 2 |
Financial Year End | 31/12/2005 |
The figures | have not been audited |
SUMMARY OF KEY FINANCIAL INFORMATION30/06/2005 |
INDIVIDUAL PERIOD | CUMULATIVE PERIOD | ||||
CURRENT YEAR QUARTER | PRECEDING YEAR CORRESPONDING QUARTER | CURRENT YEAR TO DATE | PRECEDING YEAR CORRESPONDING PERIOD | ||
30/06/2005 | 30/06/2004 | 30/06/2005 | 30/06/2004 | ||
RM'000 | RM'000 | RM'000 | RM'000 | ||
1 | Revenue | 26,487 | 20,127 | 48,692 | 39,502 |
2 | Profit/(loss) before tax | 9,355 | 6,987 | 16,823 | 14,075 |
3 | Profit/(loss) after tax and minority interest | 5,665 | 5,924 | 11,570 | 11,549 |
4 | Net profit/(loss) for the period | 5,665 | 5,924 | 11,570 | 11,549 |
5 | Basic earnings/(loss) per share (sen) | 4.31 | 4.50 | 8.78 | 8.76 |
6 | Dividend per share (sen) | 0.00 | 3.00 | 0.00 | 3.00 |
AS AT END OF CURRENT QUARTER | AS AT PRECEDING FINANCIAL YEAR END | ||||
7 | Net tangible assets per share (RM) | 0.8500 | 0.8100 |
Note: For full text of the above announcement, please access KLSE Web site at www.klse.com.my
Announcement Info
Company Name | DUOPHARMA BIOTECH BHD |
Stock Name | DBIOTEC |
Date Announced | 29 Aug 2005 |
Category | Financial Results |
Reference No | CS-050823-66601 |